According to Bloomberg Business, the world’s first dengue vaccine has been approved after 20 years of research.
See Also: World’s First Dengue Vaccine to Be Ready Next Year, According to Sanofi
The vaccine, developed by French drug maker Sanofi Pasteur, has already won clearance in Mexico. Sanofi expects to see more approvals in upcoming weeks in Latin America and Asia for the vaccine known as Dengvaxia.
According to Bloomberg, the vaccine, once injected, can prevent “all four types of the virus, which has appeared in Portugal, France, Florida and Japan recently and increased the risk of explosive outbreaks.”
Dengvaxia took 20 years to develop at a cost of 1.5 billion euros. Currently, it is waiting to be approved in 19 other countries. The vaccine, unfortunately, isn’t recommended for children under 9 years of age, because studies suggest that it protects them less well.
Read more:
- Clinical Tests Carried Out on Several Dengue Vaccines
- Surge in Dengue Cases in Malaysia
- Four More Dengue Symptoms to Look out for According to Hospital Kuala Lumpur
Source: Bloomberg Business
"ExpatGo welcomes and encourages comments, input, and divergent opinions. However, we kindly request that you use suitable language in your comments, and refrain from any sort of personal attack, hate speech, or disparaging rhetoric. Comments not in line with this are subject to removal from the site. "
THANK YOU SANOFI PASTEUR!!!
Finally…….
Just waiting for the sterlization conspiracy theories.
Yixian Quah
Hallelujah! ?
Have been following this story for a while – the tests have been ongoing for years and the success rate, although not 100%, is high! Can’t wait for it to be available here – my dengue / mosquito paranoia is a pain!!!
Alan Khoo
Great article
Wow – now that is seriously good news – if it works!